Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Leukemia

Free Subscription 01.06.2026 8 Ann Hematol 4 Blood 1 Bone Marrow Transplant 1 Cancer 1 Cancer Lett 2 Eur J Haematol 1 Exp Cell Res 1 Genes Chromosomes Cancer 1 J Biol Chem 1 Leuk Lymphoma 3 Leuk Res 5 Leukemia 1 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Hematol

1. ANGLEITNER AC, Maulhardt M, Treiber H, Hasenkamp J, et al
   Timing of donor lymphocyte infusion after relapse following allogeneic hematopoietic cell transplantation: a retrospective single-center analysis.
   Ann Hematol. 2026;105:297.
   PubMed         Abstract available
   
   
2. LI X, Zhang Y, Wei X, Huang R, et al
   A macrophage-related efferocytosis-based two-gene prognostic model for acute myeloid leukemia identified by multi-omics and machine learning.
   Ann Hematol. 2026 May 29. doi: 10.1007/s00277-026-07044.
   PubMed         Abstract available
   
   
3. CREEMERS SG, Yildirim G, Dirven CMF, Wlazlo N, et al
   Management of pseudotumor cerebri syndrome in acute promyelocytic leukemia: use of a lumboperitoneal shunt to facilitate continued ATRA therapy - a case report.
   Ann Hematol. 2026 May 27. doi: 10.1007/s00277-026-07078.
   PubMed         Abstract available
   
   
4. AKBARIN MM, Farjami Z, Alvarez HR
   Exploiting the Notch pathway in HTLV-1-driven adult T-cell leukemia/lymphoma: a mini-review.
   Ann Hematol. 2026 May 27. doi: 10.1007/s00277-026-07087.
   PubMed         Abstract available
   
   
5. PICARDI M, Giordano C, Vincenzi A, Scarpa A, et al
   Peripherally inserted central venous catheters for remission induction chemotherapy phase of acute leukemia: a single center experience in severely thrombocytopenic patients.
   Ann Hematol. 2026;105:295.
   PubMed        
   
   
6. PEI WT, Liu CL, Li XL
   Bioinformatics-driven dissection of PANoptosis-related molecular subtypes and tumor immune microenvironment heterogeneity in pediatric acute myeloid leukemia.
   Ann Hematol. 2026 May 23. doi: 10.1007/s00277-026-07082.
   PubMed         Abstract available
   
   
7. CIMINO G, Sembenico R, Zorutti F, Saldi S, et al
   Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia.
   Ann Hematol. 2026;105:293.
   PubMed         Abstract available
   
   
8. LEE S, Kim HJ, Cheong JW, Shin HJ, et al
   Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
   Ann Hematol. 2026 May 22. doi: 10.1007/s00277-026-07053.
   PubMed         Abstract available
   
   

   
   Blood

9. LING RE, Welsh AM, Hamer L, Jackson T, et al
   The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia.
   Blood. 2026 May 29:blood.2025028877. doi: 10.1182/blood.2025028877.
   PubMed         Abstract available
   
   
10. HELMAN SR, Stonestrom AJ
    Morphologic and flow cytometric features of menin inhibitor-induced pseudoprogression in KMT2A-rearranged acute myeloid leukemia.
    Blood. 2026;147:2697.
    PubMed        
    
    
11. MUFFLY L, Lee CJ, Gandhi A, Varma A, et al
    Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS.
    Blood. 2026;147:2610-2620.
    PubMed         Abstract available
    
    
12. LI L, Rottmann I, Saeed BR, Ivison G, et al
    High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression.
    Blood. 2026;147:2648-2665.
    PubMed         Abstract available
    
    

    
    Bone Marrow Transplant

13. PAVIGLIANITI A, Ngoya M, Peffault de la Tour R, Schroeder T, et al
    Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.
    Bone Marrow Transplant. 2026 May 27. doi: 10.1038/s41409-026-02920.
    PubMed         Abstract available
    
    

    
    Cancer

14. ALBLIWI M, Nurse DP, Zabor EC, Hanna J, et al
    Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impact.
    Cancer. 2026;132:e70465.
    PubMed         Abstract available
    
    

    
    Cancer Lett

15. SHAO G, Pan H, Zhu J, Zhuo N, et al
    Repurposing the Neurokinin-1 Receptor Antagonist Aprepitant to Eradicate Relapsed/Refractory Acute Lymphoblastic Leukemia via Mitochondria-Driven Necroptosis.
    Cancer Lett. 2026 May 24:218621. doi: 10.1016/j.canlet.2026.218621.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

16. SALAH AN, Mansour RM, El-Sayyad GS, Moustafa HAM, et al
    Epigenetics and In Silico Transcriptome Analysis of Pediatric Acute Myeloid Leukemia.
    Eur J Haematol. 2026 May 22. doi: 10.1111/ejh.70230.
    PubMed         Abstract available
    
    
17. BRUZZESE A, Martino EA, Caserta S, Alvaro ME, et al
    Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment.
    Eur J Haematol. 2026 May 25. doi: 10.1111/ejh.70223.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

18. ZHU X, Huang W, Zhang M, Tao Y, et al
    The ATF4/PSAT1/JNK signaling axis suppresses ferroptosis to drive venetoclax resistance in AML.
    Exp Cell Res. 2026;460:115045.
    PubMed         Abstract available
    
    

    
    Genes Chromosomes Cancer

19. NGUYEN-KHAC F, Muller M, Daudignon A, Smol T, et al
    The t(X;5)(q13;q33) Translocation in Myeloid Neoplasms Is Preferentially Associated With Chronic Myelomonocytic Leukemia: A Report From the Groupe Francophone de Cytogenetique Hematologique.
    Genes Chromosomes Cancer. 2026;65:e70143.
    PubMed         Abstract available
    
    

    
    J Biol Chem

20. MADHULIKA S, Panda TS, Samal P, Kumar SS, et al
    Dysregulated HELLS expression alters cellular processes and serves as a potential prognostic marker in acute myeloid leukemia.
    J Biol Chem. 2026 May 28:113210. doi: 10.1016/j.jbc.2026.113210.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

21. AGARWAL G, Tonk RK, Sangwan K
    Emerging drug profile: menin inhibitors in NPM1-mutated and KM2A-rearranged acute myeloid leukemia.
    Leuk Lymphoma. 2026 May 27:1-17. doi: 10.1080/10428194.2026.2674818.
    PubMed         Abstract available
    
    

    
    Leuk Res

22. CHOWDHURY S, Mandal C, Sarkar S, Bag AK, et al
    Retraction notice to "Mobilization of lymphoblasts from bone marrow to peripheral blood in childhood acute lymphoblastic leukaemia: Role of 9-O-acetylated sialoglycoproteins" [Leukemia Res. 36(2) (2012) 146-155].
    Leuk Res. 2026 May 29:108240. doi: 10.1016/j.leukres.2026.108240.
    PubMed        
    
    
23. DONG D, Chen H, Li H, Luo D, et al
    Prognostic significance of PCR-based measurable residual disease post-induction and during consolidation in pediatric KMT2A-rearranged acute myeloid leukemia.
    Leuk Res. 2026;167:108256.
    PubMed         Abstract available
    
    
24. GIORDANO U, Mordak-Domagala M, Piekarska A, Sadowska-Klasa A, et al
    Long-term outcomes of allogeneic hematopoietic stem cell transplantation in adult philadelphia chromosome-positive all treated with tyrosine kinase inhibitors in the pre-blinatumumab era. A retrospective analysis on behalf of the polish adult leukemia
    Leuk Res. 2026;167:108242.
    PubMed        
    
    

    
    Leukemia

25. TAN J, He F, Hu H, Cao W, et al
    Unraveling cellular and molecular mechanisms of relapse in CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.
    Leukemia. 2026 May 29. doi: 10.1038/s41375-026-02978.
    PubMed         Abstract available
    
    
26. FUJITA M, Ureshino H
    Clonal dynamics and therapeutic pressure in myeloproliferative neoplasm with concomitant chronic myeloid leukemia: Potential implications of JAK2-directed therapy and additional mutations.
    Leukemia. 2026 May 29. doi: 10.1038/s41375-026-02983.
    PubMed        
    
    
27. CHIU A, Seheult JN, Shi M, Jevremovic D, et al
    Artificial intelligence-enhancement of flow cytometry data accelerates the identification of measurable residual chronic lymphocytic leukemia.
    Leukemia. 2026 May 26. doi: 10.1038/s41375-026-02986.
    PubMed         Abstract available
    
    
28. HOCHHAUS A, Talpaz M, Saglio G, Cortes JE, et al
    From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.
    Leukemia. 2026 May 22. doi: 10.1038/s41375-026-02984.
    PubMed         Abstract available
    
    
29. GALE RP, Hochhaus A
    2001-2026: LEUKEMIA celebrates 25 years of tyrosine kinase inhibitors.
    Leukemia. 2026 May 22. doi: 10.1038/s41375-026-02981.
    PubMed        
    
    

    
    Oncogene

30. DELAHAYE MC, Leonard S, Pelletier J, Destin J, et al
    Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.
    Oncogene. 2026 May 23. doi: 10.1038/s41388-026-03827.
    PubMed         Abstract available
    
    

    
    PLoS One

31. YUAN Z, Chen J, Chen D, Xu G, et al
    Correction: Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats.
    PLoS One. 2026;21:e0350157.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum